Manfred has M&A, Management, Finance and Controlling expertise; Life Sciences and API Experience in Corporate Strategy and M&A, Head of BD and CFO roles. He has lived and worked in various countries (US, UK, CH, D, A) and industries (Pharma, Chemical, Communications) and gathered both, management and consulting  experience and skills. His deep understanding of the industry, of valuing and integrating businesses, makes him a valuable partner in transaction and transformation processes.

Previously:  Kybora, Cambrex, Lonza, DDB, Mobil Oil

Thomas is a successful life science corporate finance advisor, capital sourcing expert, investor and mentor. With his large network and long-standing experience in working with Life Sciences companies he’s a trusted partner to his clients. Building bridges between company owners and investors, constructing compelling equity stories, deal moderation and negotiation are his speciality.

Previously: Citi, Deutsche Bank, MP Corporate Finance

Giuseppe has substantial experience in top level strategic management positions in the Life Science industry. He excells in sales and business development, as well as global business management. He gained his extraordinary skills in the domestic (Italian) and international markets. Giuseppe combines a deep understanding of the Life Sciences industry with a deep understanding and vision on how the industry will evolve.

Previously:  Polpharma, Doppel Farmaceutici, Patheon, Pharmatec Int'l

Jon is a successful executive, investor, and advisor with a global track record of  achievement in the medical device industry. He has led numerous organizations “from good to great” and has extensive experience both, sourcing and closing transactions. Jon specializes in special situations, valuations, corporate transformation, post-merger  integration and transaction support.

Previously:  PwC, FTI, EMSA Capital, Schottentor Capital (Founder)

Dietmar is an independent consultant in the life science sector, specialized in in- and out-licensing, as well as business and corporate development. With his extensive top-level management experience, he has a extremely wide network in virtually every country of the world. Combining his  PhD in law with in-depth pharmaceutical knowledge, Dietmar excels in transforming business models with well balanced, workable and understandable contracts.

Previously:  Asta Medica (now: Mylan), Lederle (now: Pfizer), Sandoz

Hervé has extensive CDMO expertise, with particular focus on strategy and value creation, corporate acquisition and integration processes, as well as business development and cost reduction initiatives. He has had a transforming impact in CDMO on an international scale. With his creative and pragmatic problem solving skills he generates competitive advantage for his clients, defining a vision and aligning the organization to deliver it, thanks to his deep understanding of the industry.

Previously:  Famar, Masai, Renault